CD4 and neoplasm: Similarly, nonresponding melanoma patients exhibit higher frequencies of senescent CD4+ and CD8+ T cells (marked by reduced CD27/CD28 expression) compared with ICI responders, an observation validated in murine colorectal cancer models where PD‐L1 antibody fails to suppress tumor growth in aged mice [404].